510(k) Report

510(k) · Cleared

Cleared

Freestyle Tracker Diabetes Management System

K020866510(k) SpecialCleared Jun 11, 200285-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Diabetes Care, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Jun 11, 2002 as substantially equivalent to K992684 (Abbott Diabetes Care, Inc., 2000) and 3 other predicates after an 85-day review. Its family tree reaches back 4 generations to 1995. 3 of the 37 devices in its family, counting itself, have a Class I recall. 22 later devices descend from it.

Decided
Jun 11, 2002
Review
85 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
4

Its longest line of descent runs back 4 generations to K945887 (1995). 14 ancestors in all, the oldest K922888 (1992). 22 later devices descend from it, 2 citing it directly. 3 of the 37 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2000: 2 other ancestors1998: 3 other ancestors1995: 1 other ancestor1993: 1 other ancestor1996: 1 other ancestor1992: 2 other ancestors2012: 4 descendants cleared, 1 with a Class I recall12003: 1 descendant cleared2008: 1 descendant cleared2006: 2 descendants cleared2007: 2 descendants cleared2010: 3 descendants cleared, 2 with a Class I recall22005: 2 descendants cleared2015: 3 descendants cleared2009: 1 descendant cleared2011: 1 descendant cleared2013: 2 descendants clearedK945887 · Precision Q I D Blood Glucose Test Strips · Medisense, Inc. · 1995K970707 · Elect II Blood Glucose Monitoring System · Selfcare, Inc. · 1997K992684 · Freestyle Blood Glucose Monitoring System · Abbott Diabetes Care, Inc. · 2000 · recalledK012014 · Modification to Blood Glucose Monitoring System · Abbott Diabetes Care, Inc. · 20011990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 5 other ancestors3 generations back: 3 other ancestors 1 generation forward: 2 descendants2 generations forward: 7 descendants, 2 with a Class I recall23 generations forward: 5 descendants4 generations forward: 5 descendants, 1 with a Class I recall15 generations forward: 3 descendants K012014 · Modification to Blood Glucose Monitoring System · Abbott Diabetes Care, Inc. · 2001K992684 · Freestyle Blood Glucose Monitoring System · Abbott Diabetes Care, Inc. · 2000 · recalledK970707 · Elect II Blood Glucose Monitoring System · Selfcare, Inc. · 1997K945887 · Precision Q I D Blood Glucose Test Strips · Medisense, Inc. · 19950+5
  1. Root · 4 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 3 generations backK970707 Elect II Blood Glucose Monitoring SystemSelfcare, Inc. · 1997
  3. 2 generations backK992684 Freestyle Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2000 · Recalled
  4. 1 generation backK012014 Modification to Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2001
  5. This deviceK020866 Freestyle Tracker Diabetes Management SystemAbbott Diabetes Care, Inc. · 2002
  6. Descendant · cites it directly · 18 of its ownK031260 Freestyle Blood Glucose Monitoring System, Freestyle Tracker…Abbott Diabetes Care, Inc. · 2003
  7. Descendant · 2 generations on · 12 of its ownK050500 Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2005
  8. Descendant · 2 generations on · 10 of its ownK051839 Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc. · 2006 · Recalled
  9. Descendant · 2 generations on · 4 of its ownK092638 Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01…Abbott Diabetes Care, Inc. · 2010 · Recalled (Class I)
  10. Descendant · 3 generations on · 4 of its ownK070850 Freestyle Lite Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2007 · Recalled

Showing 5 of 22 descendants. See all descendants

Descendants cleared per year

2003: 12005: 22006: 22007: 22008: 12009: 12010: 32011: 12012: 42013: 22015: 3
2003high 4 (2012) · low 0 (2004)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 22 · See all
  • K031260Freestyle Blood Glucose Monitoring System, Freestyle Tracker Diabetes Management System…Abbott Diabetes Care, Inc. · 2003 · cites it directly18descendants
  • K050500Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2005 · 2 generations on12descendants
  • K051839Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc. · 2006 · 2 generations on10descendants
  • K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22…Abbott Diabetes Care, Inc. · 2010 · 2 generations on4descendants
  • K070850Freestyle Lite Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2007 · 3 generations on4descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K945887Precision Q I D Blood Glucose Test StripsMedisense, Inc.1995—
−3K970707Elect II Blood Glucose Monitoring SystemSelfcare, Inc.1997—
−2K992684Freestyle Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.20002
−1K012014Modification to Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.2001—
0 (this device)K020866Freestyle Tracker Diabetes Management SystemAbbott Diabetes Care, Inc.2002—
+1K031260Freestyle Blood Glucose Monitoring System, Freestyle Tracker Diabetes…Abbott Diabetes Care, Inc.2003—
+2K050500Freestyle 600 Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.2005—
+2K051839Free-Style Freedom Blood Glucose Monitoring System, Model 11001Abbott Diabetes Care, Inc.20062
+2K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21…Abbott Diabetes Care, Inc.2010Class I
+3K070850Freestyle Lite Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.20071

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199220
199310
199510
199610
199830
200020

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200520
200620
200720
200810
200910
201032
201110
201241
201320
201530
FIG. 1 — Lineage of K020866, 1995–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

3 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K992684Freestyle Blood Glucose Monitoring System
Summary page 1
…Predicate Device TheraSense, Inc. Manufacturer(s) Predicate Device K992684; K000582; K012014; K994433 Reference(s) Predicate Device TheraSense, Inc.,…
Abbott Diabetes Care, Inc.20002
*K000582Freestyle Blood Glucose Monitoring System, Cat NO 11001
Summary page 1
…Predicate Device TheraSense, Inc. Manufacturer(s) Predicate Device K992684; K000582; K012014; K994433 Reference(s) Predicate Device TheraSense, Inc., FreeStyl…
Abbott Diabetes Care, Inc.2000—
*K012014Modification to Blood Glucose Monitoring System
Summary page 1
…Device TheraSense, Inc. Manufacturer(s) Predicate Device K992684; K000582; K012014; K994433 Reference(s) Predicate Device TheraSense, Inc., FreeStyle Blood G…
Abbott Diabetes Care, Inc.2001—
*K994433Connect Data Management System
Summary page 1
…TheraSense, Inc. Manufacturer(s) Predicate Device K992684; K000582; K012014; K994433 Reference(s) Predicate Device TheraSense, Inc., FreeStyle Blood Glucose…
Abbott Diabetes Care, Inc.20001

Also cleared against K992684: 7 other devices →

What descends from it? (22)

See all 22

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K031260Freestyle Blood Glucose Monitoring System, Freestyle Tracker Diabetes Management System…Abbott Diabetes Care, Inc.200318
K111874Freestyle Insulinx Blood Glucose Monitoring SystemsAbbott Laboratories20122

Has anything in its family been recalled? (3 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22, 12101-23Abbott Diabetes Care, Inc. · 2010 · 2 generations on · ◆ in the 2010 descendants bar of FIG. 12 Class I recalls
  • K120568Freestyle Insulinx Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2012 · 2 generations on · ◆ in the 2012 descendants bar of FIG. 11 Class I recall
  • K092602FREESTYLE Lite Blood Glucose Monitoring System and Freestyle Freedom Lite Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2010 · 4 generations on · ◆ in the 2010 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • 4 of the 14 ancestors have a recall of any class.
  • Of its descendants, K031260 (Abbott Diabetes Care, Inc., 2003) has gone furthest, with 18 descendants of its own.
  • 7 other devices also cite its predicate K992684.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The TheraSense, Inc. FreeStyle Tracker Diabetes Management System is intended for use in the quantitative measurement of glucose in whole blood. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates. Additionally, the…

Read the full statement (138 words)

The TheraSense, Inc. FreeStyle Tracker Diabetes Management System is intended for use in the quantitative measurement of glucose in whole blood. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and it is not intended for use on neonates.

Additionally, the TheraSense, Inc. FreeStyle Tracker Diabetes Management System is intended for use in home and clinical setting to aid people with diabetes and healthcare professionals in the review, analysis, and evaluation of historical blood glucose test results to support an effective diabetes management program.

The TheraSense, Inc. FreeStyle Tracker Diabetes Management System is specifically indicated for use on the finger, forearm, upper arm, thigh, calf, and hand.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K020866: Freestyle Tracker Diabetes Management System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K020866

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026